Differential correlation for sequencing data by unknown
Siska and Kechris  BMC Res Notes  (2017) 10:54 
DOI 10.1186/s13104-016-2331-9
TECHNICAL NOTE
Differential correlation for sequencing 
data
Charlotte Siska1*  and Katerina Kechris2
Abstract 
Background: Several methods have been developed to identify differential correlation (DC) between pairs of molec-
ular features from –omics studies. Most DC methods have only been tested with microarrays and other platforms 
producing continuous and Gaussian-like data. Sequencing data is in the form of counts, often modeled with a nega-
tive binomial distribution making it difficult to apply standard correlation metrics. We have developed an R package 
for identifying DC called Discordant which uses mixture models for correlations between features and the Expectation 
Maximization (EM) algorithm for fitting parameters of the mixture model. Several correlation metrics for sequencing 
data are provided and tested using simulations. Other extensions in the Discordant package include additional mod-
eling for different types of differential correlation, and faster implementation, using a subsampling routine to reduce 
run-time and address the assumption of independence between molecular feature pairs.
Results: With simulations and breast cancer miRNA-Seq and RNA-Seq data, we find that Spearman’s correlation 
has the best performance among the tested correlation methods for identifying differential correlation. Application 
of Spearman’s correlation in the Discordant method demonstrated the most power in ROC curves and sensitivity/
specificity plots, and improved ability to identify experimentally validated breast cancer miRNA. We also considered 
including additional types of differential correlation, which showed a slight reduction in power due to the additional 
parameters that need to be estimated, but more versatility in applications. Finally, subsampling within the EM algo-
rithm considerably decreased run-time with negligible effect on performance.
Conclusions: A new method and R package called Discordant is presented for identifying differential correlation 
with sequencing data. Based on comparisons with different correlation metrics, this study suggests Spearman’s 
correlation is appropriate for sequencing data, but other correlation metrics are available to the user depending on 
the application and data type. The Discordant method can also be extended to investigate additional DC types and 
subsampling with the EM algorithm is now available for reduced run-time. These extensions to the R package make 
Discordant more robust and versatile for multiple –omics studies.
© The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Differential correlation or coexpression (DC) occurs 
when two features show dissimilar associations between 
biological groups. DC has been gaining ground as another 
approach to analyze –omics data, especially when indi-
vidual features may not show differential expression or 
abundance, but may be differentially associated among 
groups, indicating a potential biological interaction [1]. 
DC has been previously examined in both low and high-
throughput studies. For example, it was determined using 
chromatin immunoprecipitation that the mutated form 
of p53 reduces the binding of wild-type p53 to the p53 
response element p21. This mutation results in DC of p53 
with its target genes MDM2 and PIG3, when compar-
ing wild-type p53 with mutant p53 [2]. In another study, 
interleukins and tumor necrosis factor were DC between 
patients with untreated and treated paracoccidioidomy-
cosis using ELISA and lymphoproliferation assays [3]. 
In addition, a recent transcriptomics study examined 
expression differences between lean and obese siblings 
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and found that NEGR1 is a central hub in obesity-related 
DC networks [4].
Discordant, a DC method based on mixture models, 
has exclusively been tested on microarray and other plat-
forms that produce continuous and Gaussian-like data 
[5]. Several other methods have also only been validated 
using microarray data, but not on sequencing data gen-
erated from next-generation sequencing technologies [6, 
7, 8]. This is most likely because sequencing technologies 
are relatively recent compared to microarray platforms 
and they result in count data so that standard correla-
tion statistics may not be applicable. The challenge is best 
represented in comparing the methods for differential 
expression in microarrays vs. RNA-Seq. In microarrays, 
a student t test for each gene, or Empirical Bayes varia-
tion, will suffice [9] while RNA-Seq analysis often relies 
on negative binomial modeling [10–12].
Efforts to find a single best metric to measure correla-
tion for –omics data is inconclusive because performance 
depends on the distribution of the data, sample size and 
the observation of interest [13]. For example, Pearson’s 
correlation can be used when the distribution is approxi-
mately Gaussian and the user has interest in linear rela-
tionships, while Hoeffing’s D measure may be better 
suited for non-monotonic associations [13]. Two studies 
compared correlation statistics for –omics data but were 
validated using microarrays [13, 14]. In our work, we 
examine a variety of correlation statistics appropriate for 
sequencing data for the purpose of testing DC including 
Pearson’s, Spearman’s, biweight midcorrelation (BWMC) 
and a sparse compositional correlation method SparCC 
[15].
There are two R packages available for DC, DiffCorr 
and EBcoexpress [7, 16]. These packages also provide 
functions to create graphs or networks of the data in 
addition to gene module analysis. To complement these 
existing packages, our work also introduces a new R 
package called Discordant. The Discordant package has 
been developed not only for sequencing data but with 
additional extensions to make the DC analysis more flex-
ible and usable.
One of the extensions provided in Discordant is to 
increase the observable DC classes. Currently, the only 
types of DC observed are cross (associations is in oppo-
site directions between groups) or disrupted (associa-
tion is present in one group but not the other). Previous 
experimental studies have observed cases of other types 
of DC when there is an increase in association in one 
group versus the other. For example, antigen coexpres-
sion increased in women 3  days after vaginal delivery 
[17] and eotaxin and interleukin-5 coexpression was 
increased in blister fluid of patients with bullous pem-
phigoid compared to healthy patients [18]. These subtle 
increases (or decreases in association) are more difficult 
to study in current DC packages and we have made that 
option available in Discordant. The other extension pro-
vided decreases run-time when millions of feature pairs 
may be evaluated. The number of pairs is especially rel-
evant to data generated from sequencing technologies 
since the feature size (genes, miRNA, etc.) can be larger 
than data generated from microarray platforms [19].
In summary, we have included several extensions to 
the Discordant method in a new R package that broad-
ens applicability: (1) different correlation metrics for 
sequencing data, (2) more differential correlation classes 
and (3) a subsampling approach. Simulations and The 
Cancer Genome Atlas (TCGA) breast cancer sequencing 
data are used to compare performance of the correlation 
methods and extensions.
Implementation
The Discordant model is adapted from Lai et al algorithm 
to determine concordance between microarrays [20, 21]. 
The model has been previously published [5].
The R package for the Discordant method was designed 
for user flexibility. It is separated into two main functions: 
createVectors and discordantRun. The flow of 
these functions are illustrated in Fig. 1 and described fur-
ther below.
–Omics data as mandatory input for each function
Each function requires either one or two –omics 
dataset(s) as argument(s). If only one –omics dataset is 
used as an argument, the functions undergo a within –
omics analysis, where pairs of the same feature are evalu-
ated (e.g. gene–gene, metabolite–metabolite). If two 
–omics datasets are used, the functions undergo a paired 
–omics analysis, where pairs of different features are 
evaluated (e.g., gene-miRNA, gene-metabolite).
Fig. 1 Flow of Discordant R Package. Gray boxes are functions, blue 
boxes outputs and green boxes optional parameters. a Input argument 
for createVectors(). b Optional argument for createVectors(). c Output 
argument for createVectors(), input for discordantRun(). d Optional 
arguments for discordantRun(). e Outputs for discordantRun()
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createVectors
The purpose of createVectors is to determine corre-
lation coefficients. The inputs are the –omics dataset(s) 
and a group vector that indicates samples for groups 
1 and 2 (Fig.  1a). An optional parameter called cor.
method is available where the user can change the type 
of correlation (Fig. 1b). The options are Pearson, Spear-
man, BWMC and SparCC (described in detail below). 
The default value for cor.method is Pearson. The out-
put are two correlation vectors corresponding to the bio-
logical groups (Fig. 1c).
Correlation metrics
Four correlation metrics are applied to sequencing data: 
Pearson, Spearman, Biweight midcorrelation (BWMC) 
and SparCC. The commonly used Pearson correlation 
assumes that both data vectors are normally distributed, 
and is optimal for identifying linear relationships. Spear-
man correlation is rank-based and a non-parametric 
alternative that can handle non-normal data and capture 
monotonic and linear relationships. BWMC is much like 
Pearson’s correlation, except it is median-based rather than 
mean-based. It is considered more robust than Pearson’s 
correlation method since it minimizes the effect of outli-
ers on the final correlation [22]. SparCC (Sparse Compo-
sitional Correlation) correlations are approximated based 
on the dispersion of the data and the assumption that most 
feature pairs will have no correlation [15].
discordantRun
The arguments necessary for discordantRun are the 
correlation vectors and –omics dataset(s) (Fig.  1c). The 
correlation vectors are input for the Discordant algo-
rithm, and the –omics dataset(s) are used to communi-
cate whether a single –omics or double –omics analysis 
is requested. The default value for transform is TRUE, 
which transforms correlation vectors into z scores using 
Fisher’s transformation. This option was inserted into 
discordantRun instead of createVectors so users 
could generate correlation vectors independent of the R 
package.
Optional arguments are available in order to use the 
5-component mixture model or subsampling (Fig.  1d). 
The outputs are a posterior probability matrix and class 
matrix (Fig. 1e). For single –omics analyses, results in the 
output matrices are below the diagonal of the matrix and 
NAs are above the diagonal in order to avoid duplicating 
information. The posterior probability output is the dif-
ferential correlation posterior probabilities (the sum of 
the off-diagonal in the class matrix in Additional file  1: 
Figure S1d).
There are several outputs for discordantRun: dis-
cordPPMatrix, discordPPVector, classMatrix, 
classVector, probMatrix, and loglik. The out-
puts discordPPMatrix and discordPPVector 
contain the posterior probability of differential correla-
tion. The rows of discordPPMatrix are the features 
in –omics x and the columns are the features in –omics 
y (or x if within –omics analysis is being used). The class 
that had the highest probability for each feature pair are 
contained in classMatrix and classVector. The 
formatting of classMatrix is similar to discordPP-
Matrix. All complete information is in probMatrix, 
where each row represents a feature pair and nine col-
umns represent the class within the class matrix. The log 
likelihood of the data fitting the model is in the argument 
loglik.
Comparison to DiffCorr
The analysis of sequencing data by Discordant was com-
pared to DiffCorr, an R package that uses Fisher’s method 
to determine differential correlation [7]. Correlation vec-
tors were determined using createVectors() and 
then DiffCorr’s function compcorr() was used to cal-
culate p values. Simulations and biological validations 
were used to assess performance.
5‑Component normal mixture model
In the simplest model [5], a three component mixture 
model is used to define whether correlations are not pre-
sent (0), are positive (+) or are negative (−). We offer an 
option which increases the number of components to 5, 
adding correlations that are very positive (++) or very 
negative (−). This increases the parameter size from 21 
to 35 and the number of classes from 9 to 25 (Additional 
file 1: Figure S2). To run the Discordant algorithm with 5 
components instead of 3, set parameter components to 
5. The default value for components is 3.
Subsampling
Like other methods [6], the Discordant model makes a 
false assumption that molecular feature pairs are inde-
pendent of each other, but features are in multiple pairs 
which violates the independence assumption. A sub-
sampling option is included to address the assumption 
and also cut down run-time. Subsampling will run if the 
argument subsampling is set to TRUE. By default, the 
EM algorithm updates parameter estimates across all 
molecular feature pairs until the EM algorithm converges 
[23]. With the subsampling option, a subsample of corre-
lation coefficients independent of each other are sampled 
to run the EM algorithm. This is repeated for a number 
of iterations (default is 100), and the parameters of each 
mixture component from each iteration are summarized 
by their mean (Additional file 1: Figure S3 a–e). Once the 
summarized parameters of the mixture components are 
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determined, the posterior probabilities of all molecular 
features are determined (Additional file 1: Figure S3 f ).
TCGA breast cancer data
From the Cancer Genome Atlas (TCGA, http://cancerge-
nome.nih.gov), we accessed miRNA-Seq and RNA-Seq 
breast cancer data with matched subjects. Of these, there 
are 15 samples with normal (or control) tissue and 42 sam-
ples with tumor tissue. This dataset was selected because 
it had the largest sample size of control and tumor groups 
in TCGA that had matched samples with miRNA-Seq 
and RNA-Seq data. Both datasets were pre-processed and 
normalized using HTSeq filtering and TMM normaliza-
tion [24, 25]. For Peason’s correlation and BWMC [9] the 
data was also transformed using voom from the limma R 
package to create continuous values [26], otherwise the 
methods (Spearman and SparCC) were applied to nor-
malized count data. The number of features remaining 
were 212 miRNA and 19414 mRNA.
Features were further filtered by the presence of outli-
ers using the median absolute deviation (MAD) outlier 
method [27]. Even after pre-processing and normaliza-
tion, the distribution of sequencing data still is asym-
metrical, where there is large density around zero and 
long tails to the right. To determine outliers, the values 
for each feature are split by being greater or less than 
the median. The two sets of features are tested for out-
liers by the difference they have with their respective 
MAD [28]. The maximum distance of all features from 
the upper or lower MAD is used to determine if the 
feature has an outlier. The standard threshold is two or 
three times the MAD outside the median [27], but since 
we found that the variation in the sequencing data was 
more extreme we used larger thresholds. For the trans-
formed sequencing data, a threshold of 7 is used to 
retain features but still filter out those that were most 
problematic. Non-transformed data has even larger dis-
persions, so a threshold of 20 was used. The number of 
features after filtering for outliers is 16,656 for RNA-
Seq data and 200 for miRNA-Seq data for the voom-
transformed data and 17,972 for RNA-Seq and 200 for 
miRNA-Seq for non-transformed data. The code for this 
outlier method is included as a function called mad-
Outlier in the R package with an option to change the 
threshold.
Experimentally validated breast cancer miRNA not 
involved in other well-researched cancers (prostate can-
cer, melanoma, glioblastoma multiforme) were used as a 
biological validation [29, 30]. A total of 8 unique breast 
cancer miRNAs were found to be in the TCGA breast 
cancer data. Since the result are in the form of molecular 
feature pairs, breast cancer miRNAs occur in more than 
one pair. Therefore, for comparison purposes we report 





The simulation designs are explained in Additional mate-
rial and Additional file 1: Figure S4. Four correlation met-
rics (Spearman, Pearson, SparCC, BWMC) were applied 
to simulated data to assess performance in identifying 
DC molecular feature pairs. Two methods were applied 
to count data (Spearman, SparCC) and two methods 
were applied to transformed data (Pearson, BWMC). 
Spearman’s correlation was used in DiffCorr. Figure 2a, b 
shows the sensitivity and specificity of the methods.
Pearson and BWMC perform similarly, most likely 
because their models are similar except Pearson is mean-
based and BWMC is median-based (Fig. 2a, b). SparCC 
has higher performance than all other methods except 
for Spearman. Out of all correlation metrics, Spearman 
had greater area under the curve in both the ROC curve 
and the sensitivity curve. Since Spearman’s correlation 
was the metric that had the best performance, it is used 
in the simulations and biological validation for the evalu-
ations of the extensions (5-component and subsampling).
TCGA breast cancer data
To identify miRNA–mRNA pairs that may change inter-
actions due to tumor status, we evaluated miRNA and 
mRNA sequencing data from the TCGA database for 
breast cancer. Discordant was run with four different 
correlation metrics (Spearman, Pearson, BWMC and 
SparCC). In Table 1, the ranks and probability of the most 
significant pairing of a breast cancer miRNA with a gene 
is summarized from Additional file 1: Table S1. For almost 
all our benchmark breast cancer miRNA, Spearman cor-
relation finds them to be more highly significant than any 
other method. The results are similar to those in simula-
tions (Fig.  2a, b) except for SparCC. In the simulations, 
SparCC performed second to Spearman but in the biolog-
ical validation it performs worse except for Pearson.
Comparison to DiffCorr
To compare both DiffCorr and Discordant, Spearman’s 
correlation metric was used because it demonstrated bet-
ter performance in the correlation metric comparison. 
Using Spearman’s correlation, the two methods were 
similar in the simulations, with a slight advantage for Dis-
cordant, which displayed more area under the curve than 
DiffCorr (Additional file 1: Figure S4). Pearson’s correla-
tion applied to DiffCorr was also observed, and showed 
worse performance than Spearman’s correlation applied 
to DiffCorr (data not shown). However, the difference 
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with DiffCorr is more evident in the TCGA Breast Can-
cer data, where breast cancer miRNAs in the DiffCorr 
analysis showed much higher rank and FDR compared to 
Discordant (Table 1; Additional file 1: Table S1).
5‑Component normal mixture model
Simulations
The 3-component normal mixture model was compared 
to the 5-component mixture model using Spearman’s 
correlation, which performed best in the simulations 
described above. Since the 3-component mixture model 
does not have components for −− and + +, any class 
that has a −− or ++ is assumed to be − and + respec-
tively, and the status as a true positive or true negative 
is assigned appropriately. The extra classes introduced 
by the 5-component mixture model are elevated DC, 
which is when the association in one group is stronger 
than in the other group. The elevated DC classes are true 
positives in the 5-component mixture model, but in the 
3-component mixture model, these classes are desig-
nated as true negatives.
The 3 component normal mixture model has greater 
power than 5-component mixture model (Fig. 3a, b). The 
plots of the posterior probabilities of true positives and 
true negatives for the simulations show (Additional file 1: 
Figure S6a, b) that the 5-component mixture models 
are better at identifying true positives but clearly strug-
gle with true negatives. In Additional file 1: Figures S7–
S10 the distribution of posterior probabilities for DC are 
plotted for each class, and it is evident that 5 component 
mixture model struggles to make distinctions between 
the − and −− components and the +  and ++  compo-
nents. In the elevated DC case (−/−− and +/++) we 
expect high posterior probabilities in the 5-component 
mixture model but low posterior probabilities in the 
3-component mixture model. The posterior probabilities 
for 5-component are higher, but they have wide range 
whereas the posterior probabilities for the 3-compo-
nent mixture model are close to 0 with tight distribution 
a b
Fig. 2 Comparisons of correlation methods: a ROC, b Sensitivity/1-Specificity vs. rank
Table 1 Summarized TCGA breast cancer biological valida-
tion
Ranks are summarized by mean and median, and q values/FDR are summarized 
by mean. Values here are based on values in Additional file 1: Table S1
Treatment Mean rank Median rank Mean q value/FDR
Correlation method comparison
 Spearman 89 56 0.0150
 SparCC 543 387 0.0240
 Pearson 531 512 0.0600
 BWMC 294 275 0.0530
 DiffCorr 502 395 0.2100
3 components vs. 5 components
 3 89 56 0.0150
 5 683 392 0.0007
Standard EM vs. subsampling EM
 Standard EM 89 56 0.0150
 Subsampling EM 92 44 0.0048
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(Additional file 1: Figure S9). A similar situation is in the 
cases where there is no DC (Additional file 1: Figure S10), 
which we expect low posterior probabilities for both 
3-component and 5-component mixture models. In the 
classes ++/++  and −−/−− the distributions for the 
5-component mixture model are variable whereas the 
distributions for the 3-component mixture model are 
close to 0 with low variation.
The average run-time for the simulations were also 
determined, and as expected the 5-component mix-
ture model takes longer to finish (by a factor of 3) since 
there are more parameters (Additional file  1: Table S2). 
Although our simulations show reduced performance, 
this option is included for users interested in these types 
of associations.
TCGA breast cancer data
Table 1 shows the summarized ranks and posterior prob-
ability of the most significant breast cancer miRNA gene 
pair when Discordant is run with the 3- or 5-component 
mixture models (complete information in Additional 
file 1: Table S1). In terms of rank, the 3-component mix-
ture model does better but the 5-component mixture 
models have higher posterior probabilities. The final 
a b
c d
Fig. 3 Analysis of extensions. 3-Component mixture model vs. 5-component mixture model: a ROC, b Sensitivity/1-specificity vs. rank. Standard EM 
vs. Subsampling EM: c ROC, d Sensitivity/1-specificity vs. rank
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posterior probability is a summation of all DC poste-
rior probabilities (Additional file  1: Figure S1f ). For the 
3-component mixture model there are 6 out of 9 of the 
posterior probabilities for the DC classes, whereas for 5 
component mixture models there are 20 out of 25. The 
posterior probabilities for 5-component mixture models 
may be larger because a greater proportion of the total 
class posterior probabilities are used to summarize the 
final DC posterior probability.
Subsampling
Simulations
The standard EM algorithm and subsampling version of 
the EM Algorithm were compared to assess affects per-
formance. The ROC curves and the sensitivity/specificity 
are similar for the two versions (Fig. 3c, d). The distribu-
tion of posterior probabilities of True Positives (TP) and 
True Negatives (TP) for the subsampling version were 
lower for the TN and higher for TP, indicating greater 
power (Additional file 1: Figure S6c, d). This is also evi-
dent when looking at each class posterior probabilities 
separately (Additional file  1: Figures S11–S13). In addi-
tion, an advantage of the subsampling version is that the 
run-time decreases by a factor of two (Additional file 1: 
Table S2).
TCGA breast cancer data
We evaluated the results from the subsampling ver-
sion on the TCGA Breast Cancer data. The summary in 
Table 1 and details in Additional file 1: Table S1 show that 
the subsampling with EM has similar ranks for breast 
cancer miRNAs, but higher posterior probabilities than 
the standard EM implementation.
Discussion
Biological data generated from high-throughput experi-
ments do not always have a normal distribution. It is 
critical to evaluate models to ensure they are able to 
make accurate predictions with non-normal data. The 
most common example of non-normal data is that from 
sequencing, which is becoming the platform of choice 
[31]. In this study, we have demonstrated that the Dis-
cordant method is now applicable to sequencing data 
and other platforms that produce discrete or count data. 
Correlation metrics were compared in simulations and 
TCGA breast cancer data. BWMC performs similarly 
to Pearson but demonstrated more power in the bio-
logical validations. This may be because BWMC is more 
robust to the presence of outliers and non-symmetric 
distributions.
SparCC demonstrated better performance in the sim-
ulations compared to the biological validation. In the 
simulations, the correlated mRNAs to miRNAs were 
generated based on the mean of the miRNA and the 
dispersion of the mRNA. The distributions were more 
similar in the correlated pairs in the simulations than the 
feature pairs in the biological validation since their dis-
tributions shared similar parameters. SparCC predicts 
the actual values based on the dispersion of the observed 
values, therefore using two different types of –omics with 
their own unique variation may not be suitable.
Spearman’s correlation metric demonstrated the best 
performance compared to all other metrics in both the 
simulations and the biological validation. Spearman’s 
correlation is a non-parametric rank-based metric that 
makes it well suited for non-normal distributions. Using 
non-parametric methods when integrating datasets with 
different levels of variability is favorable, and may explain 
why Spearman has greater power in both simulations and 
biological validation.
Although we found improved performance with Spear-
man’s correlation in our simulations and sequencing 
data, the preferred correlation metric depends on the 
type of data and study. For example, if the user wants a 
more conservative method SparCC should be used, but 
for normal continuous data Pearson’s correlation is the 
natural choice. For these reasons, the correlation metric 
is a user-defined option in the Discordant R package.
DiffCorr and Discordant were compared to assess the 
application of sequencing data to another published dif-
ferential correlation R package. Spearman’s correlation 
metric was used since it demonstrated better performance 
compared to other metrics when applied to Discordant. It 
was not surprising that Discordant demonstrated better 
performance since we have shown in previous studies that 
Discordant’s model outperforms the Fisher’s method Diff-
Corr implements [5, 7, 32]. If DiffCorr is a more attractive 
option based on its computational simplicity compared 
to Discordant, sequencing data can be applied with the 
Spearman’s correlation metric.
Not only does the new Discordant R package provide 
more flexibility to the form of the data, it also provides 
additional modeling and implementation options com-
pared to existing software DiffCorr and EBcoexpress [7, 
16]. Expanding the normal mixture model from 3 compo-
nents to 5 components gives the user the opportunity to 
explore other types of DC, which have been documented 
in several low-throughput experiments before, and may 
be of interest to other researchers [17, 18]. The addition 
of extra classes does reduce power for Discordant, and we 
advise users to consider the 5-component mixture model 
if extreme DC is relevant to their study and a 5-compo-
nent mixture model is justifiable with model selection 
criteria such as Bayesian Information Criteria (BIC).
Furthermore, users are now able to use the subsam-
pling extension to the EM algorithm which not only 
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makes the method more computationally tractable, but 
also solves the problem of dependencies between pairs. 
There were some inconsistencies, such as the higher 
posterior probabilities for subsampling compared to the 
posterior probabilities with no subsampling even though 
the ranks between subsampling and no subsampling were 
similar. The posterior probabilities may be larger for two 
reasons: the parameters for each mixture component are 
better estimated since the independence assumption is 
no longer violated and the parameters are averaged over 
100 iterations, making standard errors small. Users apply 
subsampling they should also be aware of selection bias, 
since only correlation coefficients that are independent of 
each other are used. Another limitation of subsampling 
is that the number of independent pairs is limited by the 
dimensions of the data. Finally, the theoretical proper-
ties of subsampling for the EM algorithm are not devel-
oped to our knowledge. Despite these considerations, 
our results illustrate the computational advantage of this 
extension without compromising performance.
Both DiffCorr and EBcoexpress have visualizations in 
their R packages, but visualizations were not included 
in the Discordant R package because plots can be made 
with added-in functions or additional libraries such as 
plot() and ggplot2 [33] and graphs can be made 
with R package igraph or GUI Cytoscape [34, 35]. Dif-
fCorr has a module building option, which will be added 
to Discordant in the future. Module building is a complex 
future direction with multiple alternatives that needs to 
be thoroughly investigated to assess which application 
works best [36–42].
Conclusions
Our expanded R package Discordant provides novel flex-
ibility compared to previous versions and other software, 
with regards to data type, modeling options and implemen-
tation. To our knowledge the Discordant model may also 
be the first DC tool to be validated using negative binomial 
simulations and sequencing data. Sequencing data is argu-
ably becoming the more common platform for transcrip-
tomic and other data, therefore developing and testing new 
software to analyze sequencing data is essential.
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